Morgan Stanley Day One Biopharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,353,148 shares of DAWN stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,353,148

Previous 709,415 90.74%

Holding current value

$10.1 Million

Previous $5.63 Million 56.36%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$6.16 - $7.97 $3.97 Million - $5.13 Million	643,733 Added 90.74%	1,353,148 $8.8 Million
Q1 2025 May 15, 2025	SELL	$7.93 - $13.21 $2.94 Million - $4.9 Million	-370,853 Reduced 34.33%	709,415 $5.63 Million
Q4 2024 Feb 14, 2025	BUY	$12.46 - $16.39 $3.81 Million - $5.01 Million	305,757 Added 39.48%	1,080,268 $13.7 Million
Q3 2024 May 14, 2025	BUY	$12.72 - $16.03 $7.72 Million - $9.73 Million	607,265 Added 363.1%	774,511 $10.8 Million
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $7.72 Million - $9.73 Million	607,265 Added 363.1%	774,511 $10.8 Million
Q2 2024 May 14, 2025	SELL	$12.03 - $17.69 $11 Million - $16.2 Million	-913,022 Reduced 84.52%	167,246 $2.3 Million
Q2 2024 Oct 17, 2024	SELL	$12.03 - $17.69 $785,607 - $1.16 Million	-65,304 Reduced 28.08%	167,246 $2.3 Million
Q2 2024 Aug 14, 2024	SELL	$12.03 - $17.69 $785,607 - $1.16 Million	-65,304 Reduced 28.08%	167,246 $2.3 Million
Q1 2024 Oct 17, 2024	BUY	$13.56 - $17.46 $885,522 - $1.14 Million	65,304 Added 39.05%	232,550 $3.84 Million
Q1 2024 Aug 16, 2024	SELL	$13.56 - $17.46 $1.38 Million - $1.78 Million	-101,889 Reduced 30.47%	232,550 $3.84 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $17.46 $1.38 Million - $1.78 Million	-101,889 Reduced 30.47%	232,550 $3.84 Million
Q4 2023 Aug 16, 2024	BUY	$9.68 - $15.37 $1.62 Million - $2.57 Million	167,193 Added 99.97%	334,439 $4.88 Million
Q4 2023 Feb 13, 2024	BUY	$9.68 - $15.37 $1.7 Million - $2.71 Million	175,993 Added 111.07%	334,439 $4.88 Million
Q3 2023 Nov 15, 2023	SELL	$11.22 - $14.86 $889,274 - $1.18 Million	-79,258 Reduced 33.34%	158,446 $1.94 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $631,435 - $778,268	53,785 Added 29.24%	237,704 $2.84 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $1.23 Million - $2.26 Million	96,654 Added 110.76%	183,919 $2.46 Million
Q4 2022 Feb 14, 2023	SELL	$18.77 - $22.0 $378,027 - $443,080	-20,140 Reduced 18.75%	87,265 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $1.16 Million - $1.87 Million	70,365 Added 189.97%	107,405 $2.15 Million
Q2 2022 Oct 27, 2022	BUY	$5.72 - $17.9 $117,757 - $368,507	20,587 Added 125.13%	37,040 $662,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $117,757 - $368,507	20,587 Added 125.13%	37,040 $662,000
Q1 2022 Oct 27, 2022	SELL	$9.12 - $17.47 $187,753 - $359,654	-20,587 Reduced 55.58%	16,453 $162,000
Q1 2022 May 13, 2022	BUY	$9.12 - $17.47 $22,699 - $43,482	2,489 Added 17.82%	16,453 $162,000
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $172,103 - $289,551	10,997 Added 370.64%	13,964 $236,000
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.92 $59,340 - $82,838	2,967 New	2,967 $70,000

Others Institutions Holding DAWN

# of Institutions

188

Shares Held

69.3M

Call Options Held

127K

Put Options Held

85.5K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $549M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account